|
|
||||||||||||||
|
|
|||||||||||||||
CASE REPORT |
1 Queens Hospital, Belvedere Road, Burton-on-Trent, Staffordshire, DE13 0RB, UK
2 Queens Hospital, Burton-on-Trent and Division of Clinical Sciences, Wolverhampton University, Wolverhampton, UK
Correspondence to:
Professor T M Reynolds
Clinical Chemistry Department, Queens Hospital, Belvedere Road, Burton-on-Trent, Staffordshire, DE13 0RB, UK; tim.reynolds{at}burtonh-tr.wmids.nhs.uk
ABSTRACT
An 82 year old woman was admitted with worsening dyspnoea. Arterial blood gases were taken on air and revealed a pH of 7.39, with a partial pressure of CO2 (pCO2) of 1.2 kPa, pO2 of 19.3 kPa, HCO3 of 13.8 mmol/litre, and base excess of 16.3 mmol/litre: a compensated metabolic acidosis with hyperventilation induced hypocapnia, which is known to be a feature of lactic acidosis. There was also an increased anion gap ((Na140 + K4.0) (Cl 106 + HCO3 13.8) = 24.2 mEq/litre (reference range, 716)), consistent with unmeasured cation. Lactate was measured and found to be raised at 3.33 mmol/litre (reference range, 0.91.7). After exclusion of common causes of lactic acidosis Atorvastatin was stopped and her acidbase balance returned to normal. Subsequently, thiamine was also shown to be deficient. The acidosis was thought to have been the result of a mitochondrial defect caused by a deficiency of two cofactors, namely: ubiquinone (as a result of inhibition by statin) and thiamine (as a result of dietary deficiency).
Abbreviations: ABGs, arterial blood gases; bd, twice daily; coQ10, coenzyme Q10; HMGCoA, hydroxymethylglutaryl CoA; od, once daily; qds, four times daily; P, partial pressure
Keywords: hydroxymethylglutaryl CoA reductase inhibitor; lactic acidosis; statin; thiamine deficiency; transketolase
This article has been cited by other articles:
![]() |
S. D. Navaneethan, R. Mooney, and J. Sloand Pseudo-anion gap acidosis NDT Plus, April 1, 2008; 1(2): 94 - 96. [Full Text] [PDF] |
||||
![]() |
J. L. Seachrist, C.-M. Loi, M. G. Evans, K. A. Criswell, and C. E. Rothwell Roles of Exercise and Pharmacokinetics in Cerivastatin-Induced Skeletal Muscle Toxicity Toxicol. Sci., December 1, 2005; 88(2): 551 - 561. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |